Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.
暂无分享，去创建一个
Samuel W. Brady | J. Downing | S. Raimondi | M. Relling | Cheng Cheng | D. Campana | C. Pui | W. Evans | Chunxu Qu | C. Mullighan | R. Ribeiro | E. Coustan-Smith | D. Pei | J. Choi | J. Rubnitz | S. Karol | S. Jeha | Jun J. Yang | K. Roberts | T. Gruber | H. Inaba | Zhaohui Gu | Deqing Pei | Seth E. Karol